Sort by
Refine Your Search
-
Listed
-
Category
-
Field
-
Applications are invited for this PhD training programme to commence in September 2026. Led by the London School of Hygiene & Tropical Medicine, this PhD Programme is offered by five UK and six
-
independently and in close collaboration with in-country partners. The applicant should have an excellent academic track record that includes formal training in microbiology as well as a relevant PhD (public
-
access to cutting-edge technology across the UK healthcare and biotech sectors. Read more about the initiative here This is a unique opportunity to help build a first-of-its-kind cancer AI development
-
background in research in cardiopulmonary medicine or surgery and a PhD, although desirable, are not essential. We offer a generous reward package and benefits including: Competitive and attractive pension
-
postgraduate degree, ideally a PhD, in statistics, machine learning, or a related field. Experience of developing new statistical methods and a strong working knowledge of a statistical software package, such as
-
of the research project and develop new areas of research. The post-holder will be expected to undertake a higher degree such as a PhD during the fellowship. About You The applicant must be a medically qualified
-
29 September 2025, with potential for extension subject to funding. The post is funded by the Centre for Disease Control (CDC) of the United States and is available from 14 July 2025. The salary will
-
degree, ideally a PhD, in health economics, medical statistics, data science, epidemiology or a related field. A clear conceptual understanding of causal inference methods such as instrumental variable
-
will have a PhD in a related field, an emerging track record of outstanding publications, and well-developed plans for new research projects. This post is generously funded by the A. G. Leventis
-
PhD) while conducting highly policy relevant research. Applicants should have a postgraduate degree with MRCP or MRCS. Relevant clinical experience in providing cancer treatments, co-ordinating clinical